Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Neurological infections: the year of PML and influenza.

× No keyword cloud information.

6 in total

Review 1. Leukocyte traffic blockade as a therapeutic strategy in inflammatory bowel disease.

Authors: Giorgos Bamias; David J Clark; Jesús Rivera-Nieves
Journal: Curr Drug Targets Date: 2013-11 Impact factor: 3.465

2. Complex febrile seizures followed by complete recovery in an infant with high-titer 2009 pandemic influenza A (H1N1) virus infection.

Authors: Mandy F O'Leary; James D Chappell; Charles W Stratton; Robert M Cronin; Mary B Taylor; Yi-Wei Tang
Journal: J Clin Microbiol Date: 2010-08-11 Impact factor: 5.948

3. Mechanism of action and efficacy of RX-111, a thieno[2,3-c]pyridine derivative and small molecule inhibitor of protein interaction with glycosaminoglycans (SMIGs), in delayed-type hypersensitivity, TNBS-induced colitis and experimental autoimmune encephalomyelitis.

Authors: Nicholas Harris; Juraj Koppel; Ferenc Zsila; Stefan Juhas; Gabriela Il'kova; Faina Yurgenzon Kogan; Orly Lahmy; Gizi Wildbaum; Nathan Karin; Regina Zhuk; Paul Gregor
Journal: Inflamm Res Date: 2016-01-21 Impact factor: 4.575

Neurological infections: the year of PML and influenza.

Review 1. Leukocyte traffic blockade as a therapeutic strategy in inflammatory bowel disease.

2. Complex febrile seizures followed by complete recovery in an infant with high-titer 2009 pandemic influenza A (H1N1) virus infection.

3. Mechanism of action and efficacy of RX-111, a thieno[2,3-c]pyridine derivative and small molecule inhibitor of protein interaction with glycosaminoglycans (SMIGs), in delayed-type hypersensitivity, TNBS-induced colitis and experimental autoimmune encephalomyelitis.

Review 4. Influenza-associated neurological complications.

Review 5. Integrin-based therapeutics: biological basis, clinical use and new drugs.

6. Infections of the nervous system.